Photosensitizing Agents

"Photosensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.

Descriptor ID	D017319
MeSH Number(s)	D27.505.954.444.600 D27.505.954.600.710
Concept/Terms	Photosensitizing Agents Photosensitizing Agents Agents, Photosensitizing Photosensitizers Photosensitizing Effect Photosensitizing Effect Effect, Photosensitizing Photosensitizing Effects Effects, Photosensitizing

Below are MeSH descriptors whose meaning is more general than "Photosensitizing Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Dermatologic Agents [D27.505.954.444]
Photosensitizing Agents [D27.505.954.444.600]
Radiation-Sensitizing Agents [D27.505.954.600]
Photosensitizing Agents [D27.505.954.600.710]

Below are MeSH descriptors whose meaning is related to "Photosensitizing Agents".

Below are MeSH descriptors whose meaning is more specific than "Photosensitizing Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Photosensitizing Agents" by people in this website by year, and whether "Photosensitizing Agents" was a major or minor topic of these publications.

Bar chart showing 25 publications over 17 distinct years, with a maximum of 3 publications in 2012 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	1	2
2003	0	1	1
2005	1	0	1
2006	2	0	2
2008	0	1	1
2010	0	1	1
2012	2	1	3
2013	0	1	1
2014	0	1	1
2016	0	1	1
2017	1	0	1
2018	0	1	1
2019	0	2	2
2020	1	2	3
2021	0	2	2
2024	1	0	1

Below are the most recent publications written about "Photosensitizing Agents" by people in Profiles.

Cehelyk EK, Syed ZA. Long-term outcomes of corneal crosslinking. Curr Opin Ophthalmol. 2024 Jul 01; 35(4):315-321.

View in: PubMed
Cinar Y, Han CC, Sahin A, Syed ZA. Long term results of accelerated corneal collagen cross-linking in pediatric keratoconus. Eur J Ophthalmol. 2021 Nov; 31(6):3494-3499.

View in: PubMed
Di Nicola M, Williams BK, Hua J, Bekerman VP, Mashayekhi A, Shields JA, Shields CL. Photodynamic Therapy for Retinal Hemangioblastoma: Treatment Outcomes of 17 Consecutive Patients. Ophthalmol Retina. 2022 01; 6(1):80-88.

View in: PubMed
Iovino C, Au A, Chhablani J, Parameswarappa DC, Rasheed MA, Cennamo G, Cennamo G, Montorio D, Ho AC, Xu D, Querques G, Borrelli E, Sacconi R, Pichi F, Woodstock E, Sadda SR, Corradetti G, Boon CJF, van Dijk EHC, Loewenstein A, Zur D, Yoshimi S, Freund KB, Peiretti E, Sarraf D. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study. Am J Ophthalmol. 2020 09; 217:104-113.

View in: PubMed
Cramer G, Lewis R, Gymarty A, Hagan S, Mickler M, Evans S, Punekar SR, Shuman L, Simone CB, Hahn SM, Busch TM, Fraker D, Cengel KA. Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative-Mediated Intraperitoneal Photodynamic Therapy in a Canine Model. Photochem Photobiol. 2020 05; 96(3):684-691.

View in: PubMed
Di Nicola M, Williams BK, Srinivasan A, Al-Dahmash S, Mashayekhi A, Shields JA, Shields CL. Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome. Ophthalmol Retina. 2020 10; 4(10):1024-1033.

View in: PubMed
Shields CL, Khoo CTL, Mazloumi M, Mashayekhi A, Shields JA. Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture. Ophthalmol Retina. 2020 03; 4(3):310-319.

View in: PubMed
Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA. Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases. Ophthalmol Retina. 2020 01; 4(1):100-110.

View in: PubMed
Chan TCY, Chan JCK, Wang YM, Rapuano CJ. Survival Analysis of Corneal Densitometry After Collagen Cross-Linking for Progressive Keratoconus. Cornea. 2018 Nov; 37(11):1449-1456.

View in: PubMed
Pointdujour-Lim R, Mashayekhi A, Shields JA, Shields CL. PHOTODYNAMIC THERAPY FOR CHOROIDAL NEVUS WITH SUBFOVEAL FLUID. Retina. 2017 Apr; 37(4):718-723.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement